申请人:BRITISH BIOTECH PHARM
公开号:WO2004101537A1
公开(公告)日:2004-11-25
Compounds formula (IA) or (IB); wherein W represents HO(C=0)-, HONH(C=0)- or H(C=O)N(OH)-; X represents -O- or -S-; and R1, R2, and R3 are as defined in the description and claims, are inhibitors of matrix metalloproteinases, in particular MMP9 and/or MMP12.
化合物的结构式(IA)或(IB);其中,W代表HO(C=0)-,HONH(C=0)-或H(C=0)N(OH)-;X代表-O-或-S-;而R1、R2和R3如描述和权利要求中所定义的,是基质金属蛋白酶,特别是MMP9和/或MMP12的抑制剂。